In many types of non-brain tumor, frequent tumoral expression of PD-L1 was also reported with tumors such as ovarian carcinoma (86.7%) [24], non-small cell lung cancer (53%) [25], and colorectal cancer (36%) [26], renal cell carcinoma (32%) [27] and melanoma [28]. This evidence concerns the gene CD274 and colorectal cancer.